James Altunkaya

Search results

• 2018

  Gemtuzumab ozogamicin for untreated acute myeloid leukaemia

  Wade, R., Claxton, L., Walker, R. A. E., Altunkaya, J., Soares, M. O., Wright, K., Hodgson, R., Simmonds, M. C. & Palmer, S. J., 14 Nov 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report